Gapping down
In reaction to disappointing earnings/guidance:
- NTNX -24.3%, MAXR -20.7%, XON -15.3%, TCMD -7.9%, ALRM -6.3%, WUBA -6%, PEGI -4.6%, APPF -4.3%, PSTG -3.9%, SRCL -3.8%, KTOS -3.4%, ZIXI -3.2%, CSLT -2.8%, DDD -2.5%, TRHC -2%, CLNY -1.8%, SGMO -1.4%, NKTR -1.3%, GCAP -1.2%
Other news:
- IMGN -49.2% (announces that its Phase 3 FORWARD I trial evaluating the safety and efficacy of mirvetuximab soravtansine did not meet its primary endpoint )
- MRSN -23.8% (prices underwritten public offering of 21,250,000 shares of common stock to the public at $4.00 per share)
- TGTX -5.7% (announces proposed underwritten public offering; enters into $60mln debt financing agreement with Hercules Capital)
- TSLA -4% (Tesla confirms availability of $35,000 Model 3 and shifting sales worldwide to online only; actions will enable company to lower all vehicle prices; Musk said not expecting profitable Q1)
- NOA -3% (ticking lower; announces bought deal offering 5.00% convertible unsecured subordinated debentures)
- BNFT -2.2% (prices 5,704,758 common stock offering at $48.25/share)
Analyst comments:
- GMLP -2.3% (downgraded to Underperform from Neutral at BofA/Merrill)